| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1055-8586(99)70015-6 |
| P698 | PubMed publication ID | 10461327 |
| P2093 | author name string | Moss RL | |
| Amii LA | |||
| P2860 | cites work | Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease | Q24322810 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. | Q33493207 | ||
| Production of bile duct hyperplasia and gallstones by lithocholic acid | Q34083152 | ||
| Hepatobiliary complications of total parenteral nutrition | Q34359168 | ||
| An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis | Q38242850 | ||
| Chronic manganese intoxication | Q39058232 | ||
| Cholestasis associated with total parenteral nutrition | Q39587308 | ||
| Toxicities of methionine and other amino acids | Q39936296 | ||
| Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. | Q40461060 | ||
| Liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention | Q40961603 | ||
| Advances in parenteral nutrition | Q41246176 | ||
| Liver complications of pediatric parenteral nutrition--epidemiology | Q41686406 | ||
| The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition | Q41686411 | ||
| Hyperbilirubinemia in neonates associated with total parenteral nutrition | Q42059088 | ||
| Modulation by S-Adenosyl-L-Methionine of Hepatic Na+, K+-ATPase, Membrane Fluidity, and Bile Flow in Rats with Ethinyl Estradiol-Induced Cholestasis | Q42246018 | ||
| Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. | Q42555482 | ||
| Studies on the toxicity and efficacy of a new amino acid solution in pediatric parenteral nutrition | Q43462240 | ||
| Total parenteral nutrition-related cholestasis in infants | Q43790251 | ||
| BAPS prize lecture: New insight into mechanisms of parenteral nutrition-associated cholestasis: role of plant sterols. British Association of Paediatric Surgeons | Q48382444 | ||
| The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition | Q49180701 | ||
| Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome | Q50158260 | ||
| Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: A preliminary report | Q51124108 | ||
| Defective methionine metabolism in cirrhosis: relation to severity of liver disease. | Q51605191 | ||
| Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. | Q54072767 | ||
| Hepatic complications of total parenteral nutrition. | Q54739213 | ||
| Cholecystokinin Increases Bile Acid Synthesis with Total Parenteral Nutrition but Does Not Prevent Stone Formation | Q61854312 | ||
| Protective role of S-adenosyl-l-methionine against acetaminophen induced mortality and hepatotoxicity in mice | Q66989967 | ||
| Protective role of S-adenosyl-L-methionine on liver injury induced by D-galactosamine in rats | Q67389108 | ||
| Hepatic secretory obstruction with total parenteral nutrition in the infant | Q67509877 | ||
| S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury | Q67555817 | ||
| S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis | Q68257612 | ||
| Plasma manganese concentrations in infants and children receiving parenteral nutrition | Q69191286 | ||
| A newborn rabbit model for total parenteral nutrition: effects of nutritional components on cholestasis | Q69221216 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients | Q69965282 | ||
| Effect of cholecystokinin-octapeptide on total parenteral nutrition-induced changes in hepatic bile secretion and composition in the rat | Q70306351 | ||
| Plasma hormone concentrations during enteral and parenteral nutrition in the human newborn | Q70456122 | ||
| Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition | Q70498716 | ||
| Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study | Q70551788 | ||
| Liver cell plasma membrane lipids in manganese-bilirubin-induced intrahepatic cholestasis | Q70625915 | ||
| Hepatobiliary dysfunction during total parenteral nutrition is caused by infusate, not the route of administration | Q70649330 | ||
| Manganese toxicity in children receiving long-term parenteral nutrition | Q71060855 | ||
| Manganese toxicity and parenteral nutrition | Q71133076 | ||
| Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study | Q71466339 | ||
| Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake | Q71497621 | ||
| Pathogenesis of methionine-induced toxicity | Q71500916 | ||
| Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide | Q71512716 | ||
| Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors | Q71520675 | ||
| Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets | Q71591379 | ||
| Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations | Q71635195 | ||
| Metabolic and endocrine consequences of depriving preterm infants of enteral nutrition | Q71698605 | ||
| Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? | Q72001802 | ||
| The effect of short-term total parenteral nutrition on hepatic function in the human neonate: A prospective randomized study demonstrating alteration of hepatic canalicular function | Q72487660 | ||
| Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation | Q72663783 | ||
| S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat | Q72812599 | ||
| Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach | Q72812628 | ||
| Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis | Q73184453 | ||
| Parenteral nutrition-associated cholestasis | Q73523413 | ||
| S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver | Q73574973 | ||
| Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis | Q93644097 | ||
| Amino acids are potent inhibitors of bile acid uptake by liver plasma membrane vesicles isolated from suckling rats | Q93663810 | ||
| Growth and development of an infant receiving all nutrients exclusively by vein | Q93763197 | ||
| Total parenteral nutrition | Q93814365 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 140-147 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Seminars in pediatric surgery | Q18413009 |
| P1476 | title | New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis | |
| P478 | volume | 8 |
| Q42089971 | Alteration of canalicular transporters in a mouse model of total parenteral nutrition |
| Q44518341 | Choleretic actions of insulin-like growth factor-I, prednisolone, and ursodeoxycholic acid in rats |
| Q51017136 | Diethylhexylphthalate extracted by typical newborn lipid emulsions from polyvinylchloride infusion systems causes significant changes in histology of rabbit liver. |
| Q58557801 | Direct hyperbilirubinemia in newborns with gastroschisis |
| Q38998254 | Incidence and Risk Factors of Parenteral Nutrition-Associated Cholestasis in Omani Neonates: Single centre experience |
| Q35115614 | Parenteral Nutrition in Infants and Children |
| Q46412512 | Parenteral nutrition-associated cholestasis related to parental care |
| Q34523863 | Parenteral nutrition-associated liver complications in children |
| Q36351821 | Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation |
| Q27026472 | Pathogenesis and treatment of parenteral nutrition-associated liver disease |
| Q50630108 | Preliminary findings of long-term neurodevelopmental outcomes of infants treated with intravenous fat emulsion reduction for the management of parenteral nutrition-associated cholestasis. |
| Q53242051 | Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy. |
| Q79257976 | Study of the clinical effects of postoperative parenteral nutrition in 15 horses |
| Q46711946 | Taurine and cholestasis associated to TPN. Experimental study in rabbit model |
Search more.